A report about an ongoing trial of the drug from Raleigh-based Sprout Pharmaceuticals for treatment of low sexual desire in women finds in interim results that the so called ‘female Viagra’ can “be used safely and effectively in women with breast cancer.”
Read More
Cindy Eckert, CEO of Raleigh-based Sprout Pharmaceuticals, says the next step in an ongoing debate with the Food and Drug Administration about the firm’s female sexual dysfunction drug Addyi is up to the regulatory agency.
Read More
The U.S. Food and Drug Administration says its discussions with Raleigh-based Sprout Pharmaceuticals about its female sexual dysfunction drug Addyi are intended to avoid “confusion” about any changes in warnings regarding the drug’s use.
Read More
The US Food and Drug Administration is saying that the status of warnings about the female sexual dysfunction drug Addyi from Raleigh-based Sprout Pharmaceuticals has not changed. Sprout says it is working to resolve the issue.
Read More
Two decisions made by the Food and Drug Administration could be good news for Raleigh-based Sprout Pharmaceuticals, the making of the female sexual disfunction drug Addyi.
Read More
Cindy Eckert, CEO of Raleigh-based Sprout Pharmaceuticals is welcoming news that her firm’s so-called “female Viagra” now has competition in the market to deal with female sexual disfunction.
Read More
The move creates a rival for Addyi, the first such drug approved for women. It is made by Raleigh-based Sprout Pharmaceuticals and is known as the “female Viagra.”
Read More
Three new studies affirm that Addyi, the so-called “female Viagra” from Raleigh based Sprout Pharmaceuticals, is safe and effective with alcohol even though the FDA warns against mixing the two, the company says.
Read MoreSprout Pharmaceuticals is relaunching the “little pink pill” Addyi – also known as the “female Viagra” at half the original price.
Read More
